Education
About Us
Working with TipRanks
Follow Us
MacroGenics (MGNX)
NASDAQ:MGNX
Total Valuation
MacroGenics has a market cap or net worth of $95.27M. The enterprise value is -$20.41M.
Market Cap$95.27M
Enterprise Value-$20.41M
Share Statistics
MacroGenics has 63,090,324 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding63,090,324
Owned by Insiders11.05%
Owned by Institutions42.73%
Financial Efficiency
MacroGenics’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -51.96%.
Return on Equity (ROE)-0.58
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-51.96%
Return on Capital Employed (ROCE)-0.54
Revenue Per Employee435.01K
Profits Per Employee-196.38K
Employee Count341
Asset Turnover0.57
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MacroGenics is -3.04. MacroGenics’s PEG ratio is -0.09.
PE Ratio-3.04
PS Ratio0.00
PB Ratio1.11
Price to Fair Value1.75
Price to FCF-1.21
Price to Operating Cash Flow-1.26
PEG Ratio-0.09
Income Statement
In the last 12 months, MacroGenics had revenue of 148.34M and earned -66.97M in profits. Earnings per share was -1.07.
Revenue148.34M
Gross Profit136.04M
Operating Income-110.58M
Pretax Income-66.02M
Net Income-66.97M
EBITDA-57.37M
Earnings Per Share (EPS)-1.07
Cash Flow
In the last 12 months, operating cash flow was -69.62M and capital expenditures -2.78M, giving a free cash flow of -72.40M billion.
Operating Cash Flow-69.62M
Free Cash Flow-72.40M
Free Cash Flow per Share-1.15
Dividends & Yields
MacroGenics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.97
52-Week Price Change-68.95%
50-Day Moving Average1.45
200-Day Moving Average2.78
Relative Strength Index (RSI)46.28
Average Volume (3m)436.52K
Important Dates
MacroGenics upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
MacroGenics as a current ratio of 3.92, with Debt / Equity ratio of 47.35%
Current Ratio3.92
Quick Ratio3.92
Debt to Market Cap0.02
Net Debt to EBITDA2.53
Interest Coverage Ratio-99.17
Taxes
In the past 12 months, MacroGenics has paid 944.00K in taxes.
Income Tax944.00K
Effective Tax Rate-0.01
Enterprise Valuation
MacroGenics EV to EBITDA ratio is -1.01, with an EV/FCF ratio of -0.81.
EV to Sales0.39
EV to EBITDA-1.01
EV to Free Cash Flow-0.81
EV to Operating Cash Flow-0.85
Balance Sheet
MacroGenics has $154.14M in cash and marketable securities with $37.47M in debt, giving a net cash position of -$116.67M billion.
Cash & Marketable Securities$154.14M
Total Debt$37.47M
Net Cash-$116.67M
Net Cash Per Share-$1.85
Tangible Book Value Per Share$1.85
Margins
Gross margin is 89.78%, with operating margin of -74.54%, and net profit margin of -45.14%.
Gross Margin89.78%
Operating Margin-74.54%
Pretax Margin-44.51%
Net Profit Margin-45.14%
EBITDA Margin-38.67%
EBIT Margin-43.76%
Analyst Forecast
The average price target for MacroGenics is $4.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.20
Price Target Upside189.66% Upside
Analyst ConsensusModerate Buy
Analyst Count7
Revenue Growth Forecast255.31%
EPS Growth Forecast-141.39%